← FDA DRUG APPROVALS

FDA NDA · NDA020044

EXOSURF NEONATAL

Sponsor: GLAXOSMITHKLINE

APPLICATION
NDA020044
TYPE
NDA
ORIGINAL APPROVAL
1990-08-02
LATEST ACTION
2000-11-21
ROUTE
INTRATRACHEAL
DOSAGE FORM
FOR SUSPENSION
MARKETING STATUS
Discontinued

Products

EXOSURF NEONATALDiscontinued
CETYL ALCOHOL 12MG/VIAL, COLFOSCERIL PALMITATE 108MG/VIAL, TYLOXAPOL 8MG/VIAL · FOR SUSPENSION · INTRATRACHEAL

Approval history

2000-11-21Labeling · Supplement 4 · standardAP
1999-04-02Manufacturing (CMC) · Supplement 3 · priorityAP
1990-08-02Type 1 - New Molecular Entity and Type 4 - New Combination · Original · priorityAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →